Skip to main content
logo
Opus Genetics, Inc. (IRD)
NASDAQ: IRD · Real-Time Price · USD
3.810
+0.030 (0.79%)
Aug 6, 2026, 9:43 AM EDT - Market open

Opus Genetics Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
9.8614.210.9919.0539.850.59
Revenue Growth
-36.09%29.15%-42.30%-52.20%6665.70%-
Gross Profit
9.8614.210.9919.0539.850.59
Operating Income
-50.61-38.6-62.07-10.5618.23-22.71
Net Income
-107.61-49.59-57.53-9.9917.89-56.69
Earnings Per Share
-1.35-0.80-2.15-0.460.87-3.82
EPS Growth
------

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
88.8145.0930.3250.5242.6824.75
Total Debt
34.9300000.54
Net Cash (Debt)
53.8845.0930.3250.5242.6824.22
Net Cash Growth
66.15%48.70%-39.97%18.35%76.27%47.66%
Net Cash Per Share
0.620.721.142.342.071.63

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-38.99-35.25-25.58-1.1114.31-19.37
Free Cash Flow
-38.99-35.25-25.58-1.1114.31-19.37
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
100.00%100.00%100.00%100.00%100.00%100.00%
Operating Margin
-513.47%-271.90%-564.72%-55.45%45.74%-3854.84%
Pretax Margin
-1089.81%-349.33%-523.40%-52.36%45.68%-9625.30%
Profit Margin
-1091.82%-349.33%-523.40%-52.42%44.89%-9625.30%
FCF Margin
0.00%-248.33%-232.68%-5.84%35.92%-3288.62%

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingAug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Forward PE
-6.026.026.0214.08-
PS Ratio
26.059.903.42---